Nirsevimab is protective against RSV infections and coinfections, which suggests there is no replacement of RSV with other viruses post-nirsevimab administration.

Vitamin D supplementation during TB treatment improves patient symptoms, but does not accelerate the clearance of TB bacteria.

For patients with HPV16-positive CIN3, vaccination with a replication-incompetent Semliki Forest virus vaccine encoding HPV16 E6 and E7 is safe and shows clinical effectiveness.

The FDA has approved Ozempic (semaglutide) to reduce the risk of kidney disease worsening and cardiovascular death in those with T2D and CKD.

Compared with adults aged 65 and older, those aged 18 to 64 are more affected by long COVID neurologic symptoms.

Among adults hospitalized with influenza, Tamiflu treatment on the day of hospital admission was associated with a reduced risk for disease progression.

Referral to an infectious disease physician was the only modifiable strategy to reduce 28-day mortality among adults presenting to the ED with bacteremia.

A new strain of bird flu, H5N9, has been detected for the first time in the United States, raising concerns about how it continues to spread.

For patients with hepatitis B virus, alcohol is associated with dose-dependent increased risks for cirrhosis and hepatocellular carcinoma.

Leukocyte count is an independent predictor of future long COVID in postmenopausal women, according to study findings.

Updated recommendations were issued by the IAS-USA regarding the use of ART for treatment and prevention of HIV in adult populations.

The CIA admits it has "low confidence" in its conclusion and says both a natural origin and a research-related incident are still possible. HealthDay News — After years of speculation, the CIA has ...